Stent graft delivery system
Medtronic, Inc., has received Food and Drug Administration approval for its Xcelerant Delivery System for use with the AneuRx® AAA Stent Graft System for the treatment of abdominal aortic aneurysms. The Xcelerant is designed for greater control and improved deliverability. Kink-resistant catheter material improves trackability through tortuous arteries, and its integrated handle aids in precise placement of the stent. A distal radiopaque marker provides improved visibility during angiography for more accurate deployment.
Articles in this issue
Electronic medical records program
Cardiac resynchronization therapy device
Stent graft delivery system
Essential characteristics of clinical research and strength of evidence
Yes, we can prevent coronary heart disease in women
The primary prevention of coronary heart disease in women: An overview
HDL better predictor of ischemic stroke than LDL, triglycerides
Prehypertension raises risk of stroke; risk is greater in African Americans
AHA issues guidelines for noninvasive testing in women with suspected CAD
Related Content
